Mammalian phospholipase D physiological and pathological roles
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Phospholipase D (PLD), a superfamily of signalling enzymes that most commonly generate the lipid second messenger phosphatidic acid, is found in diverse organisms from bacteria to humans and functions in multiple cellular pathways. Since the early 1980s when mammalian PLD activities were first described, most of the important insights concerning PLD function have been gained from studies on cellular models. Reports on physiological and pathophysiological roles for members of the mammalian PLD superfamily are now starting to emerge from genetic models. In this review, we summarize recent findings on PLD functions in these model systems, highlighting newly appreciated connections of the superfamily to cancer, neuronal pathophysiology, cardiovascular topics, spermatogenesis and infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 1×
“…a balance between the synthesis, degradation and subsequent recycling of cellular products and decreases in autophagy have been linked to major diseases such as cancer, diabetes and neurodegeneration (Rubinsztein et al. 2007, Kundu & Thompson 2008, Mizushima et al. 2008, Tooze & Schiavo 2008).”
BackgroundThe Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 2×
“Some of the key components that regulate mitochondrial dynamics have been identified, including the Mitofusins, Mfn1 and Mfn2 (Chen et al. 2003), which are critical for mitochondrial fusion and the dynamin-related GTPase Drp1 (Smirnova et al. 2001), which plays a key role in fission.”
BackgroundTwenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322 · cited 2×
“2009) to suppress cancer cell apoptosis (Sabatini 2006).”
BackgroundPhosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling
Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., & Chen, J. (2001) · Science · doi:10.1126/science.1066015 · Cited by 1,055 · cited 1×
“A hypothesis that has been widely explored concerns potential roles for PLD and its product PA in activating mTOR (Fang et al. 2001, Toschi et al. 2009) to suppress cancer cell apoptosis (Sabatini 2006).”
BackgroundAutophagy: Basic Principles and Relevance to Disease
Kundu, M., & Thompson, C. B. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.091842 · Cited by 523 · cited 1×
“…a balance between the synthesis, degradation and subsequent recycling of cellular products and decreases in autophagy have been linked to major diseases such as cancer, diabetes and neurodegeneration (Rubinsztein et al. 2007, Kundu & Thompson 2008, Mizushima et al. 2008, Tooze & Schiavo 2008).”
BackgroundPhospholipase D in endocytosis and endosomal recycling pathways
Donaldson, J. G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.05.011 · Cited by 92 · cited 1×
“PA, lyso-PA and DAG all have effects on multiple cellular pathways, including intracellular vesicle trafficking, endocytosis, exocytosis, actin cytoskeleton dynamics, cell proliferation, differentiation, migration and survival (Jenkins & Frohman 2005, Donaldson 2009, Rudge & Wakelam 2009).”
Background
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Role of Phospholipids in Endocytosis, Phagocytosis, and Macropinocytosis
Bohdanowicz, M., & Grinstein, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2012 · Cited by 311
Teasdale, R. D., & Collins, B. M. (2012) · Biochemical Journal · doi:10.1042/bj20111226 · Cited by 281
Metabolic features of the cell danger response
Naviaux, R. K. (2014) · Mitochondrion · doi:10.1016/j.mito.2013.08.006 · Cited by 232
Targeting phospholipase D in cancer, infection and neurodegenerative disorders
Brown, H. A., Thomas, P. G., & Lindsley, C. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.252 · Cited by 209
“(PI(4,5)P2) were found to be stimulators of PLD activity in extracts from HL60 cells 103 and porcine brain(104).”
BackgroundInfluential
Metadata
- Authors
- Peng, X., & Frohman, M. A.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2011-05-28
- Volume
- 204
- Issue
- 2
- Pages
- 219-226
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2164362108
- Cited by
- 140
- References
- 8
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.